Skip to main content

Facing the Reality of Drug-Resistant Tuberculosis in India Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research (2012) / Chapter Skim
Currently Skimming:

Appendix B: Summary of a Joint Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and Indian Biomedical Research Agencies, Held April 20-21, 2011, New Delhi, India
Pages 141-144

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 141...
... The goals of the joint workshop were to: • share the latest state-of-the-art scientific information on drug dis covery research designed to help combat MDR and extensively drug-resistant (XDR) TB; • summarize TB drug development projects of the pharmaceutical industry and the public sector currently under way; • discuss TB drug development needs and ways in which biomedical research can contribute; • identify partnership opportunities to advance and accelerate new drug discovery efforts so that therapeutic options for drug-resistant TB can be advanced and accelerated; 141
Read the entire page →
From page 142...
... At the conference, during a session convened by the Institute of Medicine (IOM) , Barbara Laughon, NIAID; Gail Cassell, Harvard Medical School and Infectious Disease Research Institute; and several participants cited conclusions and recommendations emerging from the meeting that were especially important in the context of the recently completed workshop summarized herein.
Read the entire page →
From page 143...
... in animal models and in vitro are particularly promising, and NIAID can provide technical preclinical assistance in this area. • Although it is a notable research challenge, new approaches to iden tifying and eliminating dormant mycobacteria are greatly needed and should be given high priority by the research community.
Read the entire page →

Key Terms

  • drug development
  • drug susceptibility
  • workshop summarized
  • research challenge
  • recent progress

  • gail cassell
  • conduct surveys
  • clinical trials
  • shop summarized
  • efforts centered

  • competitive research
  • forum brought
  • effective treatments
  • university laboratories
  • disease research

  • recommendations emerging
  • therapeutic options
  • development assistance
  • identify effective
  • notable research

  • tuberculosis drug
  • combat mdr
  • niaid offers
  • cited conclusions
  • included researchers

  • summarized herein
  • ideas emerging
  • industrial drug
  • session convened
  • participants included


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.